|
FOR RELEASE ON |
27 October 2022 |
IP Group plc - SAYE Option Exercise
IP Group plc (LSE: IPO) ("IP Group" or "the Group" or "the Company"), which develops world-changing science and technology businesses across life sciences, technology and cleantech, announces the following in connection with its employee share schemes.
SAVE AS YOU EARN ("SAYE") SHARESAVE PLAN
Four of the Group's persons discharging managerial responsibilities ("PDMRs") exercised SAYE options under the Group's 2019 SAYE plan to buy a total of 104,447 ordinary shares of two pence each ("Shares") at 51.7 pence per share.
In addition, other Group employees have exercised SAYE options over a total of 147,409 Shares.
The exercise of these options will be satisfied through the transfer of 251,856 Shares which the Group currently holds in treasury on or around 1 November 2022.
Shares in issue
At the date of this announcement, the Company continues to have 1,063,188,005 Shares in issue and 28,607,622 Shares held in treasury.
The following notifications, made in accordance with the requirements of article 19.3 of the EU Market Abuse Regulation, provide further details:
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.
|
1 |
Details of the person discharging managerial responsibilities/person closely associated |
|||||||
|
a) |
Name |
Angela Leach |
||||||
|
2 |
Reason for the notification |
|||||||
|
a) |
Position/status |
PDMR Group General Counsel & Company Secretary
|
||||||
|
|
Initial notification /Amendment |
Initial Notification |
||||||
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||||
|
a) |
Name |
IP Group plc |
||||||
|
b) |
Legal Entity Identifier |
213800HG22UM138WFG43 |
||||||
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||||
|
a) |
Description of the financial instrument, type of instrument Identification code |
Ordinary Shares of 2p each in IP Group plc |
||||||
|
b) |
Nature of the transaction |
Exercise of an option to acquire Ordinary Shares under the Group's 2019 SAYE. |
||||||
|
c) |
Currency |
GBP |
||||||
|
d) |
Price(s) and volume(s) |
|
||||||
|
e) |
Aggregated information -Aggregated volume - Price - Aggregated total |
6,963
£0.517 £3,599.88
|
||||||
|
f) |
Date of the transaction |
19 October 2022 |
||||||
|
g) |
Place of the transaction |
London
|
||||||
|
2 |
Details of the person discharging managerial responsibilities/person closely associated |
|||||||
|
a) |
Name |
Sam Williams |
||||||
|
2 |
Reason for the notification |
|||||||
|
a) |
Position/status |
PDMR Managing Partner, Life Sciences
|
||||||
|
|
Initial notification /Amendment |
Initial Notification |
||||||
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||||
|
a) |
Name |
IP Group plc |
||||||
|
b) |
Legal Entity Identifier |
213800HG22UM138WFG43 |
||||||
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||||
|
a) |
Description of the financial instrument, type of instrument Identification code |
Ordinary Shares of 2p each in IP Group plc |
||||||
|
b) |
Nature of the transaction |
Exercise of an option to acquire Ordinary Shares under the Group's 2019 SAYE. |
||||||
|
c) |
Currency |
GBP |
||||||
|
d) |
Price(s) and volume(s) |
|
||||||
|
e) |
Aggregated information -Aggregated volume - Price - Aggregated total |
34,816
£0.517 £17,999.88
|
||||||
|
f) |
Date of the transaction |
18th October 2022 |
||||||
|
g) |
Place of the transaction |
London
|
||||||
|
3 |
Details of the person discharging managerial responsibilities/person closely associated |
|||||||
|
a) |
Name |
Lisa Patel |
||||||
|
2 |
Reason for the notification |
|||||||
|
a) |
Position/status |
PDMR Partner, Life Sciences
|
||||||
|
|
Initial notification /Amendment |
Initial Notification |
||||||
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||||
|
a) |
Name |
IP Group plc |
||||||
|
b) |
Legal Entity Identifier |
213800HG22UM138WFG43 |
||||||
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||||
|
a) |
Description of the financial instrument, type of instrument Identification code |
Ordinary Shares of 2p each in IP Group plc |
||||||
|
b) |
Nature of the transaction |
Exercise of an option to acquire Ordinary Shares under the Group's 2019 SAYE. |
||||||
|
c) |
Currency |
GBP |
||||||
|
d) |
Price(s) and volume(s) |
|
||||||
|
e) |
Aggregated information -Aggregated volume - Price - Aggregated total |
27,852
£0.517 £14,399.49
|
||||||
|
f) |
Date of the transaction |
18th October 2022 |
||||||
|
g) |
Place of the transaction |
London
|
||||||
|
4 |
Details of the person discharging managerial responsibilities/person closely associated |
|||||||
|
a) |
Name |
Douglas Moray Wright |
||||||
|
2 |
Reason for the notification |
|||||||
|
a) |
Position/status |
PDMR CEO, Parkwalk
|
||||||
|
|
Initial notification /Amendment |
Initial Notification |
||||||
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||||
|
a) |
Name |
IP Group plc |
||||||
|
b) |
Legal Entity Identifier |
213800HG22UM138WFG43 |
||||||
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||||
|
a) |
Description of the financial instrument, type of instrument Identification code |
Ordinary Shares of 2p each in IP Group plc |
||||||
|
b) |
Nature of the transaction |
Exercise of an option to acquire Ordinary Shares under the Group's 2019 SAYE. |
||||||
|
c) |
Currency |
GBP |
||||||
|
d) |
Price(s) and volume(s) |
|
||||||
|
e) |
Aggregated information -Aggregated volume - Price - Aggregated total |
34,816
£0.517 £17,999.88
|
||||||
|
f) |
Date of the transaction |
19th October 2022 |
||||||
|
g) |
Place of the transaction |
London
|
||||||
For more information, please contact:
|
IP Group plc |
|
|
David Baynes, Chief Financial and Operating Officer |
+44 (0) 20 7444 0050 |
Notes for editors
About IP Group
IP Group develops world-changing science and technology businesses across life sciences, technology and cleantech (through Kiko Ventures). The Group has a strong track record of success, having been the founder investor in a number of high-profile companies including Oxford Nanopore Technologies plc, and has one of the most exciting portfolios of high-growth businesses in Europe. The Group also owns Parkwalk, the UK's largest growth EIS fund manager which backs world-changing technologies emerging from the UK's leading universities and research institutions. IP Group is listed on the Main Market of the London Stock Exchange under the code IPO.
For more information, please visit our website at www.ipgroupplc.com.
ENDS
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
